Login / Signup

COVID-19 in patients with pulmonary alveolar proteinosis: a European multicentre study.

Spyros A PapirisIlaria CampoFrancesca MarianiMaria KallieriLykourgos KolilekasAndriana I PapaioannouEfsun Gonca ChouseinErdogan CetinkayaFrancesco BonellaRaphael BorieMaria KokosiThomas PickworthMaria Molina-MolinaMercè GasaElżbieta RadzikowskaJustyna FijolekStéphane JouneauEmmanuel GomezCormac McCarthyElizabeth BendstrupWojciech J PiotrowskiRishi PabaryAlice HadchouelNathalie Coolen-AllouTiago M AlfaroCarlos Robalo CordeiroElvira-Markela AntonogiannakiIoannis P TomosDespoina PapakostaTheodoros KontakiotisPanagiota PanagiotouKonstantinos DourosAndrea SchamsSara LettieriVassiliki PapaevangelouChristina Kanaka-GantenbeinAnna KarakatsaniStelios LoukidesUlrich CostabelBruno CrestaniCliff MorganRyushi TazawaAndrew BushMatthias GrieseEffrosyni D Manali
Published in: ERJ open research (2023)
Adult PAP patients experience similar #COVID19 rates to the general population, and high rates of hospitalisation and deaths, underscoring their vulnerability and the need for measures to prevent infection. The impact of iGM-CSF must be considered. https://bit.ly/3M0wKnZ.
Keyphrases
  • coronavirus disease
  • sars cov
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • pulmonary hypertension
  • prognostic factors
  • peritoneal dialysis
  • respiratory syndrome coronavirus